Table 1.
Survival times.
| Female | Male | |||||
|---|---|---|---|---|---|---|
| C57BL/6 | APP/PS1 | APPNL-F/NL-F | C57BL/6 | APP/PS1 | APPNL-F/NL-F | |
| N | 257 | 562 | 128 | 172 | 573 | 126 |
| Survival Days to: | ||||||
| 80% Remaining | 27 | 24 | 615 | 27 | 27 | 246 |
| 50% Remaining | 564 | 28 | 782 | 359 | 120 | 816 |
| 20% Remaining | 829 | 131 | 882 | 891 | 839 | 945 |
Survival times.
| Female | Male | |||||
|---|---|---|---|---|---|---|
| C57BL/6 | APP/PS1 | APPNL-F/NL-F | C57BL/6 | APP/PS1 | APPNL-F/NL-F | |
| N | 257 | 562 | 128 | 172 | 573 | 126 |
| Survival Days to: | ||||||
| 80% Remaining | 27 | 24 | 615 | 27 | 27 | 246 |
| 50% Remaining | 564 | 28 | 782 | 359 | 120 | 816 |
| 20% Remaining | 829 | 131 | 882 | 891 | 839 | 945 |